An acute shortage of drugs to treat symptoms of COVID-19 has led to increased circulation of counterfeit medicines in recent times, a company statement said. It added that there are reports of fake antiviral medicines and spurious injectable immunosuppressants in the market.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3zFvm59
via IFTTT
0 comments:
Post a Comment